Uttar Pradesh, India

Shailendr Dubey


 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shailendr Dubey: Innovator in Pharmaceutical Processes

Introduction

Shailendr Dubey is a notable inventor based in Uttar Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medicinal compounds. With a total of 2 patents to his name, Dubey's work is recognized for its innovation and practical applications.

Latest Patents

Dubey's latest patents include a process for the preparation of Lurasidone hydrochloride. This invention discloses an improved method for producing Lurasidone and its pharmaceutically acceptable salts through a novel intermediate. The process is designed to be cost-effective and eco-friendly, producing Lurasidone hydrochloride at an industrial scale while being substantially free of residual solvents. Another significant patent is for the preparation of azilsartan medoxomil. This invention relates to an improved method for synthesizing azilsartan or its esters or salts, focusing on the production of a highly pure intermediate compound with reduced impurity content.

Career Highlights

Throughout his career, Shailendr Dubey has worked with reputable companies such as Jubilant Life Sciences Limited and Jubilant Generics Limited. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical technologies.

Collaborations

Some of his notable coworkers include Alka Srivastava Choudhary and Dharam Vir. Their collaboration has likely fostered an environment of innovation and shared expertise in their respective fields.

Conclusion

Shailendr Dubey's contributions to pharmaceutical processes highlight his role as an innovator in the industry. His patents reflect a commitment to improving the efficiency and sustainability of drug production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…